drugset
drugset / Trial / NCT01160614

Pharmacokinetics and Safety of ORF Tablets in Pediatric Patients

NCT01160614 ↗

Phase 1 Completed 30 enrolled Purdue Pharma LP
NaSingle-groupOpen-label

Summary

The purpose of this study is to characterize the pharmacokinetics (PK) of single-dose ORF tablets in pediatric patients aged 6 to 16 years, inclusive.

Timeline

Start
2010-07
Primary completion
2011-08
Completion
2011-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Oxycodone Other / unclassified 10 mg —
Subject Oxycodone Other / unclassified 15 mg —
Subject Oxycodone Other / unclassified 20 mg —

Indications

No indication recorded.